Long-Term Outcomes and Valve Performance in Patients Undergoing Transcatheter Aortic Valve Implantation

Transcatheter aortic valve implantation (TAVI) is an equal therapeutic strategy to surgery in patients with symptomatic severe aortic valve stenosis (AS) at low, medium and high surgical risk1-4. One of the few remaining issues with transcatheter heart valves is the long-term durability and valve performance. The aim of this study was to determine the long-term clinical outcomes and valve performance beyond 5 years with the first and second generation of a self-expanding bioprosthesis.

https://www.ajconline.org/article/S0002-9149(21)00146-6/fulltext?rss=yes

Source: The American Journal of Cardiology - February 19, 2021 Category: Cardiology Authors: Konstantinos Stathogiannis, Andreas Synetos, George Latsios, Antonios Karanasos, George Trantalis, Pantelis Toskas, Maria Drakopoulou, Maria Xanthopoulou, Maria Karmpalioti, Chryssa Simopoulou, Stergios Soulaidopoulos, George Oikonomou, Georgios Benetos, Source Type: research